Literature DB >> 8915293

MR imaging, CT and CEA scintigraphy in the diagnosis of local recurrence of rectal carcinoma.

L Blomqvist1, T Holm, H Göranson, H Jacobsson, H Ohlsén, S A Larsson.   

Abstract

PURPOSE: To compare advanced imaging techniques in the diagnosis of recurrent rectal cancer.
MATERIAL AND METHODS: Twenty-five consecutive patients with either suspected or verified recurrence were examined by CT (n = 25), MR with phased-array capabilities (n = 24) and CEA scintigraphy (n = 16). Three experienced radiologists (who were blinded to results obtained at surgery and histopathology) independently evaluated the films, one observer for each modality.
RESULTS: The MR radiologist arrived at a correct diagnosis in 87.5% of the examinations, the CT radiologist in 76% and the CEA radiologist in 75%. The MR radiologist's results correlated more often with reported pathology than did those of the CT radiologist with regard to the relation of recurrent tumor to surrounding structures in the pelvis.
CONCLUSION: MR imaging is the most effective of the 3 modalities in the diagnosis of recurrent rectal cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8915293     DOI: 10.1177/02841851960373P270

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  12 in total

1.  [Recurrent rectal cancer: diagnosis by contrast enhancement in MD-CT].

Authors:  C A Stückle
Journal:  Radiologe       Date:  2005-11       Impact factor: 0.635

2.  [Improvements in detection of rectal cancer recurrence by multiplanar reconstruction].

Authors:  C A Stückle; K F Haegele; M Jendreck; R Kickuth; O Schneider; G Hohlbach; D Liermann
Journal:  Radiologe       Date:  2005-10       Impact factor: 0.635

3.  Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58.

Authors:  Yun-Feng Yao; Zhi Yang; Zhen-Fu Li; Jin Gu
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

4.  Significance of mesorectal volume in staging of rectal cancer with magnetic resonance imaging and the assessment of involvement of the mesorectal fascia.

Authors:  Michael R Torkzad; Karl A Hansson; Johan Lindholm; Anna Martling; Lennart Blomqvist
Journal:  Eur Radiol       Date:  2006-12-21       Impact factor: 5.315

Review 5.  Surveillance after curative treatment for colorectal cancer.

Authors:  Eric P van der Stok; Manon C W Spaander; Dirk J Grünhagen; Cornelis Verhoef; Ernst J Kuipers
Journal:  Nat Rev Clin Oncol       Date:  2016-12-20       Impact factor: 66.675

6.  What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis : imaging for recurrent colorectal cancer.

Authors:  Monique Maas; Iris J G Rutten; Patty J Nelemans; Doenja M J Lambregts; Vincent C Cappendijk; Geerard L Beets; Regina G H Beets-Tan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-06       Impact factor: 9.236

7.  Value of MRI and diffusion-weighted MRI for the diagnosis of locally recurrent rectal cancer.

Authors:  Doenja M J Lambregts; Vincent C Cappendijk; Monique Maas; Geerard L Beets; Regina G H Beets-Tan
Journal:  Eur Radiol       Date:  2011-01-16       Impact factor: 5.315

Review 8.  Pelvic colorectal recurrence: crucial role of radiologists in oncologic and surgical treatment options.

Authors:  P A Georgiou; P P Tekkis; G Brown
Journal:  Cancer Imaging       Date:  2011-10-03       Impact factor: 3.909

Review 9.  Detection of recurrent rectal cancer with CT, MRI and PET/CT.

Authors:  O Schaefer; M Langer
Journal:  Eur Radiol       Date:  2007-04-03       Impact factor: 7.034

10.  The importance of rectal cancer MRI protocols on interpretation accuracy.

Authors:  Chikako Suzuki; Michael R Torkzad; Soichi Tanaka; Gabriella Palmer; Johan Lindholm; Torbjörn Holm; Lennart Blomqvist
Journal:  World J Surg Oncol       Date:  2008-08-20       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.